| Metric | Grade | Score | Evidence | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | C+ | 58 | Mixed signals: hyper-growth revenue (+46.8% YoY) offset by negative earnings (-$1.02 EPS), tight valuation (forward P/E 8.86), low beta (0.68) provides stability. | 6–12M |
| SA Quality/Value Composite | C | 52 | Forward P/E 8.86 is attractive, but negative earnings and absent profitability flags underscore low quality. Revenue growth is strong but not profitable growth. | 6–12M |
| Zacks Earnings Momentum | D+ | 42 | EPS -$1.02; no forward guidance visible. EPS growth YoY unavailable. Earnings profitability flag false. High uncertainty on earnings inflection. | 3–6M |
| Institutional & Smart Money Flow | B– | 72 | Low beta (0.68) suggests defensive institutional positioning. Dividend yield 3.64% attracts income-focused institutions. Volume data limited; price up +1.25% intraday. | 1–3M |
| Growth Sustainability & Moat | C+ | 61 | Hyper-growth flag active (revenue +46.8% YoY). However, banking sector requires proven deposit stability, market share, and margin expansion—not disclosed. Growth may be acquisition-driven or cyclical. | 6–12M |
| Valuation & Safety (Pre-Penalty) | B | 78 | Forward P/E 8.86 is below peers and market; market cap $162M is micro-cap. Beta 0.68 reduces systematic risk. Dividend support (3.64 yield, $0.73/share) adds safety cushion. | 6–12M |
| Penalty Overlay | –15 | –15 | Negative EPS, missing P/E (profitability gap), no earnings date disclosed, micro-cap liquidity risk, coverage constrained. Data gaps on TTM revenue, guidance, and balance sheet strength. | Immediate |
| CONFIDENCE SCORE | C+ | 61 | Data coverage 60%: pricing, dividend, forward P/E solid. Missing: profitability verification, earnings trajectory, insider flows, institutional ownership. High-conviction thesis impossible. | 6–12M |
| Volatility & Drawdown Risk | B+ | 82 | Beta 0.68 is defensive. 52-week range $7.31–$11.71 shows 60% max drawdown possible but low daily churn (+1.25% today). Micro-cap means liquidity shocks possible. | 3–12M |
| Crowding Risk Flag | LOW | 18 | Micro-cap $162M, limited avg volume (0.23M shares), no analyst target mean, minimal research coverage. Underowned but illiquid—crowding unlikely but also minimal exit liquidity. | Ongoing |
BCB Bancorp (BCBP) is a micro-cap regional bank ($162M market cap) trading at a forward P/E of 8.86x—below regional bank peers (typical 10–13x) and the broader financial sector. The forward valuation is mechanically attractive, but the negative TTM EPS of –$1.02 signals either a recent loss period or integration costs from acquisitions. Revenue growth of +46.8% YoY is exceptional for a regional bank and likely reflects acquisition activity or market expansion rather than organic deposit/lending growth. The 3.64% dividend yield is supported by a $0.73/share payout, suggesting management confidence in earnings recovery. Low beta (0.68) positions BCBP as a defensive holding relative to regional bank peers, which typically range 1.0–1.4 beta. However, micro-cap illiquidity (0.23M avg volume) and limited analyst coverage constrain institutional participation and create execution risk on entry/exit.
1–3 Month Horizon (Tactical):
BCBP is likely to track sideways to slightly higher as a micro-cap recovery play. The +1.25% intraday move suggests modest institutional nibbling. Key watch: Q2/Q3 earnings announcement (earnings_date not disclosed in live data) to verify if EPS inflects positive. Dividend sustainability must be confirmed; if earnings remain negative, payout may be at risk. Liquidity is the primary tactical risk—position size must be limited due to 0.23M avg volume. Target: $9.20–$9.50 if earnings stabilize.
6–12 Month Horizon (Structural):
Success hinges on proving that hyper-growth revenue (+46.8%) converts to normalized GAAP profitability within two quarters. If BCBP returns to positive EPS and sustains mid-30%+ revenue growth, the valuation multiple could expand to 12–14x forward, implying $12–$14 fair value. Conversely, if revenue growth slows below 20% YoY and EPS remains negative, downside to $6.50–$7.50 is plausible (down to the 52-week low of $7.31). The low-beta defensive profile makes BCBP suitable for income-focused portfolios, but high-growth equity investors should demand clarity on earnings inflection before committing capital.
BCBP Stock Analysis & Forecast
Is BCBP a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
BCBP Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, BCBP shows balanced risk-reward characteristics.
Should You Buy BCBP Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in BCBP.